Do Not Reuse Recovered Solvents Without Testing and GMP Documentation

Do Not Reuse Recovered Solvents Without Proper Testing and Documentation

Remember: GMP mandates that recovered solvents be reused only after thorough testing, specification compliance, and complete documentation approved by QA.

Why This Matters in GMP

Solvent recovery is a cost-saving practice in pharmaceutical manufacturing, especially in processes involving large volumes of organic solvents. However, recovery does not guarantee purity. Recovered solvents may contain residues, impurities, or degradation products, which, if reused without adequate testing, could compromise product quality and safety. GMP allows solvent reuse only when strict analytical testing confirms that the solvent meets predefined quality specifications equivalent to fresh solvent. Any deviation or unqualified reuse can lead to batch failures, contamination, or regulatory action.

Also Read: Keep Laminar Airflow Cabinets Active During Aseptic Operations

Improper reuse of solvents also affects consistency in critical quality attributes (CQA) and poses cross-contamination risks across different product streams. Documenting every step—from recovery to reuse—ensures traceability and accountability, both of which are essential to GMP integrity.

Regulatory and Compliance Implications

FDA 21 CFR Part 211.94 and 211.101 require that all components, including solvents, meet identity and purity specifications. EU GMP Chapter 5 permits solvent reuse only when they meet appropriate standards and are used under controlled conditions. WHO GMP

and Schedule M demand validation and documentation for recovered material reuse. Auditors examine recovery logs, QC test reports, reuse justifications, and QA approvals. Unapproved or undocumented reuse may result in critical audit observations and potential enforcement action.

Also Read: Immediately Isolate and Decontaminate Spillage in GMP Processing Areas

Implementation Best Practices

Establish specifications and analytical methods for each recovered solvent in accordance with pharmacopeial or internal standards.
Test every recovered batch for identity, purity, moisture, and residual solvents before reuse.
Maintain recovery and reuse logs showing quantity recovered, batch number, date, and testing data.
Incorporate reuse justification into BMRs and link it to QA-approved testing reports.
Revalidate recovery and reuse processes periodically and after major process changes or deviations.

Regulatory References

FDA 21 CFR Part 211.94 and 211.101 – Component Specifications and Identity
EU GMP Chapter 5 – Recovered Material Usage Control
WHO GMP – Solvent Recovery and Reuse Procedures
Schedule M – Solvent Management in GMP Manufacturing

Also Read: Never Rely on Electronic Signatures Without System Validation